Cyclerion Therapeutics, Inc. (CYCN) has a market capitalization of $13.12M and trades at $3.03. The 52-week range is 1.027-8.48.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.8, Earnings Per Share (EPS) of $-1.09, annual revenue of $2.07M.
The stock has a beta of 0.93, operates in the Healthcare sector.
